Artelo Biosciences, Inc.
ARTL
$1.04
$0.010.97%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -77.58% | -62.24% | -59.96% | -50.86% | -40.53% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -60.47% | -77.13% | -7.36% | -35.88% | -29.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -76.71% | -62.87% | -57.76% | -50.03% | -40.07% |
|
|
|||||
| Total Current Assets | -76.71% | -62.87% | -57.76% | -50.03% | -40.07% |
| Net Property, Plant & Equipment | 371.43% | 272.41% | 197.44% | 148.00% | -65.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | -98.48% | 0.00% | 0.00% |
| Total Assets | -63.98% | -53.96% | -50.67% | -43.97% | -36.14% |
|
|
|||||
| Total Accounts Payable | 35.62% | -25.36% | 65.01% | -13.41% | 36.80% |
| Total Accrued Expenses | 103.33% | -14.29% | -4.35% | -4.60% | -43.40% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 52.17% | 6.25% | -2.94% | -16.22% | -42.50% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 37.26% | -24.32% | 55.89% | -12.61% | 29.36% |
|
|
|||||
| Total Current Liabilities | 37.26% | -24.32% | 55.89% | -12.61% | 29.36% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 1,350.00% | 540.00% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 42.60% | -15.85% | 68.64% | -2.74% | 26.44% |
|
|
|||||
| Common Stock & APIC | 1.78% | 1.77% | 2.87% | 2.94% | 3.13% |
| Retained Earnings | -24.38% | -24.49% | -30.00% | -28.94% | -29.94% |
| Treasury Stock & Other | 0.49% | -9.55% | -1.00% | 0.98% | 20.08% |
| Total Common Equity | -75.69% | -56.37% | -55.13% | -45.93% | -39.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -75.69% | -56.37% | -55.13% | -45.93% | -39.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -75.69% | -56.37% | -55.13% | -45.93% | -39.43% |
|
|
|||||